NL7315827A - - Google Patents

Info

Publication number
NL7315827A
NL7315827A NL7315827A NL7315827A NL7315827A NL 7315827 A NL7315827 A NL 7315827A NL 7315827 A NL7315827 A NL 7315827A NL 7315827 A NL7315827 A NL 7315827A NL 7315827 A NL7315827 A NL 7315827A
Authority
NL
Netherlands
Application number
NL7315827A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7315827A publication Critical patent/NL7315827A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
NL7315827A 1972-12-06 1973-11-19 NL7315827A (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2259646A DE2259646C2 (de) 1972-12-06 1972-12-06 Hochdosierte Tabletten von Cephalosporin-Derivaten sowie Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
NL7315827A true NL7315827A (cg-RX-API-DMAC10.html) 1974-06-10

Family

ID=5863650

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7315827A NL7315827A (cg-RX-API-DMAC10.html) 1972-12-06 1973-11-19

Country Status (12)

Country Link
US (1) US3931404A (cg-RX-API-DMAC10.html)
JP (1) JPS5710843B2 (cg-RX-API-DMAC10.html)
AT (1) AT338431B (cg-RX-API-DMAC10.html)
BE (1) BE808302A (cg-RX-API-DMAC10.html)
CA (1) CA1038758A (cg-RX-API-DMAC10.html)
CH (1) CH609244A5 (cg-RX-API-DMAC10.html)
DE (1) DE2259646C2 (cg-RX-API-DMAC10.html)
FR (1) FR2209547B1 (cg-RX-API-DMAC10.html)
GB (1) GB1457546A (cg-RX-API-DMAC10.html)
NL (1) NL7315827A (cg-RX-API-DMAC10.html)
SE (1) SE427724B (cg-RX-API-DMAC10.html)
ZA (1) ZA739243B (cg-RX-API-DMAC10.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4143129A (en) 1975-10-11 1979-03-06 Lilly Industries Limited Cephalexin tablets
US4115563A (en) * 1977-03-14 1978-09-19 Sterling Drug Inc. Pharmaceutical steroid formulation
US4250166A (en) 1977-05-27 1981-02-10 Shionogi & Co., Ltd. Long acting preparation of cefalexin for effective treatments of bacterial infection sensitive to cefalexin
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
ES2079327B1 (es) * 1994-12-13 1996-08-01 Lilly Sa Formulaciones farmaceuticas de cefaclor.
US5837292A (en) * 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
WO2004100880A2 (en) * 2003-05-06 2004-11-25 Nirmal Mulye Controlled release formulation of erythromycin derivatives
KR20080083071A (ko) * 2003-08-08 2008-09-12 아지노모토 가부시키가이샤 나테글리니드 함유 제제
WO2005016311A1 (en) * 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
EP1883393A2 (en) * 2005-05-05 2008-02-06 Lupin Ltd. Stabilized oral pharmaceutical compositions of cephalosporins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL263687A (cg-RX-API-DMAC10.html) *
GB1132583A (en) * 1964-12-16 1968-11-06 Glaxo Lab Ltd Pharmaceutical compositions containing cephalosporins
GB1195203A (en) * 1966-06-24 1970-06-17 Glaxo Lab Ltd Cephalosporins
US3573294A (en) * 1968-03-14 1971-03-30 Glaxo Lab Ltd 7 - (arylglyoxamido)cephalosporanic acids and their salts and alpha-carbonyl derivatives
DE2117762A1 (de) * 1970-11-06 1972-05-10 Takahashi Hitoshi Behandlung von Alopecia und pharmazeutische Präparation für die Durchführung der Behandlung

Also Published As

Publication number Publication date
AU6319073A (en) 1975-06-05
SE427724B (sv) 1983-05-02
CH609244A5 (cg-RX-API-DMAC10.html) 1979-02-28
DE2259646C2 (de) 1984-11-22
BE808302A (fr) 1974-06-06
JPS4986526A (cg-RX-API-DMAC10.html) 1974-08-19
GB1457546A (en) 1976-12-01
US3931404A (en) 1976-01-06
JPS5710843B2 (cg-RX-API-DMAC10.html) 1982-03-01
ATA1017173A (de) 1976-12-15
CA1038758A (en) 1978-09-19
DE2259646A1 (de) 1974-06-12
AT338431B (de) 1977-08-25
ZA739243B (en) 1974-10-30
FR2209547B1 (cg-RX-API-DMAC10.html) 1977-09-02
FR2209547A1 (cg-RX-API-DMAC10.html) 1974-07-05

Similar Documents

Publication Publication Date Title
FR2209547B1 (cg-RX-API-DMAC10.html)
JPS4921383U (cg-RX-API-DMAC10.html)
JPS4920232A (cg-RX-API-DMAC10.html)
JPS4986274A (cg-RX-API-DMAC10.html)
CS153936B1 (cg-RX-API-DMAC10.html)
CS154024B1 (cg-RX-API-DMAC10.html)
CS152690B1 (cg-RX-API-DMAC10.html)
JPS4910950U (cg-RX-API-DMAC10.html)
CS153919B1 (cg-RX-API-DMAC10.html)
CS154487B1 (cg-RX-API-DMAC10.html)
CS154184B1 (cg-RX-API-DMAC10.html)
CH568085A5 (cg-RX-API-DMAC10.html)
CH599224A5 (cg-RX-API-DMAC10.html)
CH574977A5 (cg-RX-API-DMAC10.html)
CH592161A5 (cg-RX-API-DMAC10.html)
CH573279A5 (cg-RX-API-DMAC10.html)
CH567161A5 (cg-RX-API-DMAC10.html)
CH582150A5 (cg-RX-API-DMAC10.html)
CH578862A5 (cg-RX-API-DMAC10.html)
CH572951A5 (cg-RX-API-DMAC10.html)
CH571105B5 (cg-RX-API-DMAC10.html)
BG17922A1 (cg-RX-API-DMAC10.html)
CH594019A5 (cg-RX-API-DMAC10.html)
CH561468A5 (cg-RX-API-DMAC10.html)
BG18223A1 (cg-RX-API-DMAC10.html)

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
BV The patent application has lapsed